NASDAQ Composite ended the session with Amgen jumping 1.84% to $242.12 on Thursday, following last session’s upward trend. NASDAQ Composite fell 0.04% to $13,123.94, after two consecutive sessions in a row of gains, on what was a somewhat rough trend trading session today.
Amgen today’s close was $242.12, 9.44% under its 52-week high of $264.97.
Amgen’s sales growth is 6.3% for the present quarter and 3.2% for the next. The company’s growth estimates for the current quarter is a negative 6.3% and positive 1% for the next.
Year-on-year quarterly revenue growth grew by 12%, now sitting on 24.99B for the twelve trailing months.
Amgen’s last day, last week, and last month’s average volatility was 0.49%, 0.39%, and 0.21%, respectively.
Amgen’s last day, last week, and last month’s high and low average amplitude percentage was 1.38%, 1.72%, and 1.94%, respectively.
Amgen’s Stock Yearly Top and Bottom Value
Amgen’s stock is valued at $242.12 at 16:28 EST, below its 52-week high of $264.97 and way higher than its 52-week low of $177.05.
Amgen’s Moving Average
Amgen’s worth is above its 50-day moving average of $228.42 and above its 200-day moving average of $238.77.